|
|
|
|
LEADER |
00000cam a2200000xa 4500 |
001 |
b11537200 |
003 |
CoU |
005 |
20210115100838.2 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
051223s2006 enka ob 001 0 eng d |
019 |
|
|
|a 276790890
|a 648335355
|a 995040277
|a 1000441437
|a 1015214726
|a 1065085388
|a 1065110194
|a 1077298097
|a 1084402463
|
020 |
|
|
|a 0203492447
|q (electronic bk.)
|
020 |
|
|
|a 9780203492444
|q (electronic bk.)
|
020 |
|
|
|a 9781842142295
|q (cased)
|
020 |
|
|
|a 1842142291
|
020 |
|
|
|z 1842142291
|q (cloth)
|
035 |
|
|
|a (OCoLC)tfe62737277
|
035 |
|
|
|a (OCoLC)62737277
|z (OCoLC)276790890
|z (OCoLC)648335355
|z (OCoLC)995040277
|z (OCoLC)1000441437
|z (OCoLC)1015214726
|z (OCoLC)1065085388
|z (OCoLC)1065110194
|z (OCoLC)1077298097
|z (OCoLC)1084402463
|
037 |
|
|
|a tfe9780429209017
|
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d OCLCQ
|d CAI
|d IDEBK
|d OCLCQ
|d E7B
|d OCLCQ
|d OCLCF
|d CRCPR
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OTZ
|d TYFRS
|d OCLCQ
|d OCLCO
|d UAB
|d STF
|d OCLCA
|d OCLCQ
|d NLE
|d OCLCO
|d OCLCQ
|d COO
|d UKMGB
|d WYU
|d OCLCA
|d VT2
|d OCLCQ
|d LEAUB
|
049 |
|
|
|a GWRE
|
050 |
|
4 |
|a QP751
|b .L55557 2006eb
|
245 |
0 |
0 |
|a Lipids and atherosclerosis
|h [electronic resource] /
|c edited by C.J. Packard and D.J. Rader ; foreword by V. Fuster.
|
260 |
|
|
|a London ;
|a New York :
|b Taylor & Francis,
|c 2006.
|
300 |
|
|
|a 1 online resource (xiv, 238 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent.
|
337 |
|
|
|a computer
|b c
|2 rdamedia.
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
490 |
1 |
|
|a Advances in translational medical science.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t Chapter 1 The assembly of very low density lipoproteins in the liver /
|r S-O. Olofsson and L. Asp --
|t chapter 2 Cardiovascular implications of partial, tissue-specific silencing of MTP /
|r C.C. Shoulders --
|t chapter 3 Acyl CoA: Diacylglycerol acyltransferases (DGATs) as therapeutic targets for cardiovascular disease /
|r J.S. Millar and J.T. Billheimer --
|t chapter 4 The biochemical and physiological roles of ACAT1 and ACAT2 in cholesterol homeostasis and atherosclerosis /
|r R.G. Lee and L.L. Rudel --
|t chapter 5 Overview of intestinal lipid metabolism /
|r T.A. Miettinen and H. Gylling --
|t chapter 6 The role of non-cholesterol sterols in the pathogenesis of atherosclerosis and their modulation by the sitosterolaemia locus /
|r E.L. Klett and S.B. Patel --
|t chapter 7 FXR: the molecular link between bile acid and lipid metabolism /
|r T. Claudel E. Sturm B. Staels F. Kuipers --
|t chapter 8 Overview of HDL and reverse cholesterol transport /
|r P. Barter --
|t chapter 9 LXR as a therapeutic target for atherosclerosis /
|r I.G. Schulman and R.A. Heyman --
|t chapter 10 Endothelial lipase and the regulation of HDL metabolism /
|r K.O. Badellino and W. Jin --
|t chapter 11 Cholesteryl ester transfer protein (CETP) inhibition as a therapeutic strategy for raising HDL-cholesterol levels and reducing atherosclerosis /
|r D.J. Rader --
|t chapter 12 Overview of insulin resistance and the metabolic syndrome /
|r N. Sattar B. Mukhopadhyay --
|t chapter 13 Peroxisome proliferator activated receptors and energy metabolism /
|r P. Gervois, J-C. Fruchart and B. Staels --
|t chapter 14 Adipocytes and their secretory products /
|r J.B. Prins --
|t chapter 15 Regulation of adipocyte triglyceride storage /
|r F. Karpe and G.D. Tan --
|t chapter 16 Role of innate immunity in atherosclerosis: immune recognition, immune activation and the atherosclerotic process /
|r J-M. Fernández-Real --
|t chapter 17 Role of CD44 in atherogenesis and its potential role as a therapeutic target /
|r E. Puré --
|t chapter 18 Lipoxygenases: potential therapeutic target in atherosclerosis /
|r L. Zhao and C.D. Funk --
|t chapter 19 Role of secretory phospholipase A2 isozymes (Lp-PLA2) /
|r C.H. Macphee.
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Lipids.
|0 http://id.loc.gov/authorities/subjects/sh85077296.
|
650 |
|
0 |
|a Atherosclerosis
|x Etiology.
|0 http://id.loc.gov/authorities/subjects/sh2009116135.
|
650 |
|
0 |
|a Atherosclerosis
|x Treatment.
|
650 |
|
7 |
|a Atherosclerosis
|x Etiology.
|2 fast
|0 (OCoLC)fst00820011.
|
650 |
|
7 |
|a Atherosclerosis
|x Treatment.
|2 fast
|0 (OCoLC)fst00820020.
|
650 |
|
7 |
|a Lipids.
|2 fast
|0 (OCoLC)fst00999367.
|
700 |
1 |
|
|a Packard, Christopher J.
|0 http://id.loc.gov/authorities/names/n88211209
|1 http://isni.org/isni/0000000124529839.
|
700 |
1 |
|
|a Rader, Daniel John.
|0 http://id.loc.gov/authorities/names/n89656516
|1 http://isni.org/isni/0000000029681111.
|
776 |
0 |
8 |
|i Print version:
|t Lipids and atherosclerosis.
|d London ; New York : Taylor & Francis, 2006
|z 1842142291
|w (OCoLC)56876271.
|
830 |
|
0 |
|a Advances in translational medical science.
|0 http://id.loc.gov/authorities/names/n2005184357.
|
856 |
4 |
0 |
|u https://colorado.idm.oclc.org/login?url=https://www.taylorfrancis.com/books/9780429209017
|z Full Text (via Taylor & Francis)
|
907 |
|
|
|a .b115372003
|b 10-19-21
|c 01-22-21
|
998 |
|
|
|a web
|b 04-12-21
|c b
|d b
|e -
|f eng
|g enk
|h 0
|i 1
|
907 |
|
|
|a .b115372003
|b 05-03-21
|c 01-22-21
|
907 |
|
|
|a .b115372003
|b 04-12-21
|c 01-22-21
|
944 |
|
|
|a MARS - RDA ENRICHED
|
915 |
|
|
|a I
|
956 |
|
|
|a Taylor & Francis eBooks
|
956 |
|
|
|b Taylor & Francis All eBooks
|
999 |
f |
f |
|i 02abc4d0-e724-5ea0-8154-7fc03f50a51f
|s 9df17bb3-56df-5b80-9541-5bec72c6e5e1
|
952 |
f |
f |
|p Can circulate
|a University of Colorado Boulder
|b Online
|c Online
|d Online
|e QP751 .L55557 2006eb
|h Library of Congress classification
|i web
|n 1
|